參考文獻：
1. Pollack, A., et al., Viral myocarditis--diagnosis, treatment options, and current controversies. Nat Rev Cardiol, 2015. 12(11): p. 670-80.
2. Alhogbani, T., Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med, 2016. 36(1): p. 78-80.
3. Farcas, G.A., et al., Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis, 2005. 191(2): p. 193-7.4. Alexander, L.K., et al., An experimental model for dilated cardiomyopathy after rabbit coronavirus infection. J Infect Dis, 1992. 166(5): p. 978-85.5. Turner, A.J., J.A. Hiscox, and N.M. Hooper, ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci, 2004. 25(6): p. 291-4.6. Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020. 395(10223): p. 497-506.7. Wang, D., et al., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020.8. Lippi, G., C.J. Lavie, and F. Sanchis-Gomar, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis, 2020.9. Chen, C., et al., [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19]. Zhonghua Xin Xue Guan Bing Za Zhi, 2020. 48(0): p. E008.10. Xu, Z., et al., Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020.